| |
|
|
|
|
| October 22 ,
2009 | ISSUE NUMBER 121 VOL 6 |
Strategy
Pfizer Profits Spike as Wyeth Deal Becomes a Reality
The third quarter reports are in, and Pfizer’s profits are up but sales are down. The company is compensating for looming patent expirations with layoffs and restructuring; is it enough to boost sales?
Sales Management
AstraZeneca, BMS Announce Layoffs and Buyouts
AZ reveals that it’s offering a buyout to every salesperson on staff, while BMS cuts jobs in Indiana. Meanwhile, all eyes are on Pfizer to see who survives the Wyeth merger.
New & Noteworthy
The Book on Daniel
Novartis CEO Daniel Vasella has built the Swiss firm into the fastest growing pharma in the world, and in the process gained a reputation as an outspoken visionary. But is he really as good as all that?
Deals
IMS Health Looking for Suitors
One of healthcare’s biggest data suppliers is looking for strategic alternatives. Some say the company already has offers on the table. Could a sale be on the horizon?
Podcast
Emerging Pharma Leadership Awards — Elizabeth Mutisya
“We need to do a better job of delineating the value our industry provides in addressing medical problems. Health economics allows us to better quantify the benefits of our solutions to patient outcomes, health-related quality of life, and individuals involved in patient care.” Listen to the Podcast for more coverage.
|
Advertisement:
Rich opportunities for your clinical trials are emerging increasingly in non-traditional markets. But diverse regulatory requirements and varying timelines may be keeping you from exploring opportunities in these regions. How can you realize the potential recruitment advantages, cost-savings and efficiencies?  Watch our webcast
to hear five Quintiles experts share insights to help you navigate the global regulatory landscape — and find your new development edge. |
 |
|  Health.com partnered with RightHealth.com, a health site developed and run by Kosmix; they will go to market together in 2010 as Health.com Integrated Solutions // Integrated Solutions
NovaBay Pharmaceuticals named Mark Anderson chief scientific officer// Mike Rutstein launches Strikeforce Communications, a new healthcare marketing agency
// The board of directors of the HealthWell Foundation appointed Mary P. Sundeen executive director // Ikaria CEO Daniel Tassé has been named chairman of the board // Peregrine Pharmaceuticals made Robert Garnick head of regulatory affairs
//
|
Advertisement:
Do you have the workload but not the workforce?
Lancaster Laboratories' Professional Scientific Staffing places our people at your site dedicated to the success of your projects. Professional Scientific Staffing keeps local jobs local, while eliminating your headcount, co-employment and project management worries. Partner and prosper with Professional Scientific Staffing.
 Click here to learn more
|
October 28 Disclosure of Drug Promotion Expenses: How Automated Reporting and Master Data Management Can Improve Compliance and Lower Costs
Wednesday, October 28, 2009 at 11AM EDT
December 2 Risk, Reward and the Pharmaceutical Life Cycle: Managing Information as a Strategic Productivity Asset
Wednesday, December 2, 2009 at 11AM ET
|
Nov 9–10, 2009 Annual Defining Appropriate and Effective Interactions with Thought Leaders and Key Opinion Leaders,
Princeton, NJ
Nov 17–18, 2009 3rd Annual Evidence-Based Medicine and Comparative Effectiveness Research Summit for the Bio/Pharmaceutical and Medical Device Industries,
Philadelphia, PA
Dec 8–9, 2009 Forum on FDA’s Structured Product Labeling, Washington, DC
Jan 21–22, 2010 Bio/Pharmaceutical Forum on Optimizing the Use of Complex Data Assets,
Philadelphia, PA
Jan 25–26, 2010 Bio/Pharmaceutical Forum on Strategic Sourcing and Procurement,
Philadelphia, PA
Feb 8–9, 2010 3rd Annual Clinical Trial Forecasting and Budgeting, Philadelphia, PA
|
|
|
|
 |
|
 |
|
 |
| This strategy of proactive engagement with non-traditional constituencies will succeed and preserve the industry business model and operating profits in the vital US market. |
|
|
|
|
You are subscribed to Pharm Exec Direct..
To unsubscribe,
click here
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
